Depression is a common symptom that comes with patients suffering from lung cancer. During the journey from lung cancer diagnosis to its treatment, involves significant time and various treatment processes. Some patients…
Month: October 2021
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Early NSCLC
The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumors express PD-L1=1%, as determined…
Lung Cancer Treatment May Impact Daily Function in Elderly Patients
According to the new research published in Journal of the American Geriatrics Society, older adults with lung cancer may experience decline in life-space mobility during lung cancer treatment. The study has been…
Study Finds New Possibilities for Lung Cancer Treatment in ‘Never Smokers’
Smoking is the well-known reason for causing lung cancer among a significant amount of people. But, there are also those lung cancer patients who have never smoked in their life but still…